https://orcid.org/0000-0003-1692-9028
References
- Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001;12(3):369–381. doi:10.1046/j.1540-8167.2001.00369.x
- NHS. Implantation of a cardiac resynchronisation therapy defibrillator (CRT-D); 2019. Available from: https://www.ouh.nhs.uk/patienImt-guide/leaflets/files/12323Pcrt-d.pdf. Accessed May 19, 2023.
- Sears SF, Shea JB, Conti JB. How to respond to an implantable cardioverter-defibrillator shock. Circulation. 2005;111(23):e380–e382. doi:10.1161/CIRCULATIONAHA.104.508663
- NICE [TA314]. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure. Available from: https://www.nice.org.uk/guidance/ta314/chapter/1-Guidance. Accessed April 21, 2022.
- Murgatroyd F, Linker N, Cunningham D, Cunningham M, Bradley A, Lange A. National audit of cardiac rhythm management devices. Nicor. 2016;2016:1.
- Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237. doi:10.1056/NEJMoa043399
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol. 2018;72(14):e91–e220. doi:10.1016/j.jacc.2017.10.054
- Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122(23):2359–2367. doi:10.1161/circulationaha.110.960633
- Turakhia MP, Zweibel S, Swain AL, Mollenkopf SA, Reynolds MR. Healthcare utilization and expenditures associated with appropriate and inappropriate implantable defibrillator shocks. Circ Cardiovasc Qual Outcomes. 2017;10(2):e002210. doi:10.1161/CIRCOUTCOMES.115.002210
- Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589–594. doi:10.1161/hc0502.103330
- Auricchio A, Schloss EJ, Kurita T, et al. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: painFree SST trial primary results. Heart Rhythm. 2015;12(5):926–936. doi:10.1016/j.hrthm.2015.01.017
- Regoli F, Graf D, Schaer B, et al. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the prospective study on predictive quality with preferencing painFree ATP therapies (4P). BMC Cardiovasc Disord. 2019;19(1):146. doi:10.1186/s12872-019-1121-4
- Rao A, Barker D, Kam Chuen MJ N, Hughes S, Cullen D. Shock rates in an unselected real world cohort of patients with Medtronic Protecta implantable cardioverter defibrillators. Cardiovasc Disord Med. 2017;2. doi:10.15761/CDM.1000140
- R Foundation. The R project for statistical computing; 2021.
- NHS. National Tariff Payment System. NHS; 2021.
- NHS. Liverpool heart and chest hospital; 2022. Available from: https://www.lhch.nhs.uk/research/. Accessed February 3, 2022.
- Arenal A, Proclemer A, Kloppe A, et al. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace. 2016;18(11):1719–1725. doi:10.1093/europace/euw032
- Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the multicenter automatic defibrillator trial-II. Am J Cardiovasc Drugs. 2009;9(6):393–400. doi:10.2165/11317980-000000000-00000
- Suwanpasak A, Boonyapisit W. The quality of life in implantable cardioverter defibrillator patients. J Med Assoc Thai. 2014;97(3):S108–14.
- Bhavnani SP, Giedrimiene D, Coleman CI, Guertin D, Azeem M, Kluger J. The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study. Pacing Clin Electrophysiol. 2014;37(10):1315–1323. doi:10.1111/pace.12465
- Shiga MDT, Suzuki MDT, Nishimura MDK. Psychological distress in patients with an implantable cardioverter defibrillator. J Arrhythm. 2013;29(6):310–313. doi:10.1016/j.joa.2013.05.006
- Hirsh AT, Sears SF Jr., Conti JB. Cognitive and behavioral treatments for anxiety and depression in a patient with an implantable cardioverter defibrillator (ICD): a case report and clinical discussion. J Clin Psychol Med Settings. 2009;16(3):270–279. doi:10.1007/s10880-009-9160-0
- Ahmed FZ, Fullwood C, Zaman M, et al. Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK retrospective observational study. PLoS One. 2019;14(1):e0206611. doi:10.1371/journal.pone.0206611